# Transfer Pricing Benchmarking

Access timely, comprehensive data on profit margins and royalty rates — automated insights for strategic intercompany transactions

Archived sample configuration. Sample data is illustrative, not live data.

Build this in Jsonify: https://factory.jsonify.com/setup?q=i+want+to+get+comprehensive%2C+timely+data+on+arm%27s+length+profit+margins+and+royalty+rates+for+comparable+intercompany+transactions+from+public+financial+filings+and+global+intellectual+property+registry+websites.

## Goal

i want to get comprehensive, timely data on arm's length profit margins and royalty rates for comparable intercompany transactions from public financial filings and global intellectual property registry websites.

## Sources

- sec.gov

- marketwatch.com

- edgar-online.com

- royaltyrange.com

- ipo.gov.uk

- uspto.gov

- spglobal.com

- bloomberg.com

- morningstar.com

## Sample data

id | Source | Transaction | Industry | Royalty Rate (%) | Profit Margin (%) | Year

1 | https://sec.gov/edgar/searchedgar/companysearch.html | Syncrude Oil Sands Project - Alberta Crown Agreement | Energy / Oil & Gas | 1.0 | 10.0 | 1975

2 | https://edgar-online.com/companies | Cystic Fibrosis Drug License (Trikafta) | Biotech / Pharma | 9.0 | 30.0 | 2020

3 | https://edgar-online.com/companies | Respiratory Inhaler Drug License (Trelegy Ellipta) | Pharmaceuticals | 6.5 | 18.0 | 2022

4 | https://edgar-online.com/companies | Multiple Sclerosis Drug License (Tysabri) | Biotech / Pharma | 18.0 | 35.0 | 2017

5 | https://edgar-online.com/companies | Oncology Drug License (Imbruvica) | Biotech / Pharma | 6.0 | 50.0 | 2013

6 | https://edgar-online.com/companies | Genetic Disorder Therapy License (Evrysdi) | Biotech / Pharma | 10.0 | 20.0 | 2023

7 | https://edgar-online.com/companies | Prostate Cancer Drug License (Xtandi) | Biotech / Pharma | 4.0 | 15.0 | 2016

8 | https://edgar-online.com/companies | Hematology Drug License (Promacta) | Biotech / Pharma | 8.0 | 25.0 | 2019

9 | https://edgar-online.com/companies | Psoriasis Drug License (Tremfya) | Pharmaceuticals | 7.0 | 15.0 | 2021

10 | https://edgar-online.com/companies | Kidney Cancer Drug License (Cabometyx/Cometriq) | Biotech / Pharma | 3.0 | 30.0 | 2021

11 | https://bloomberg.com/markets | Smartphone Patent Portfolio Licensing Deal | Technology / Electronics | 5.0 | 30.0 | 2025

12 | https://marketwatch.com/tools/quotes | Cloud Software Subscription License Agreement | Software / IT Services | 10.0 | 40.0 | 2024

13 | https://spglobal.com/en/research-insights | Solar Panel Technology License | Energy / Renewables | 4.0 | 18.0 | 2023

14 | https://morningstar.com/stocks | Retail Brand Licensing Agreement | Retail / Fashion | 8.0 | 12.0 | 2022

15 | https://ipo.gov.uk/p-ipsum | Aerospace Patent Licensing Framework (UK) | Aerospace | 7.0 | 18.0 | 2024

16 | https://uspto.gov/patents/search | Green Technology Patent License (US) | Clean Energy | 4.5 | 20.0 | 2025

17 | https://marketwatch.com/tools/quotes | Augmented Reality Device Patent License | Consumer Electronics | 4.5 | 25.0 | 2024

18 | https://spglobal.com/en/research-insights | Electric Vehicle Charging Tech License | Automotive | 3.0 | 10.0 | 2023

19 | https://bloomberg.com/markets | Media Streaming Platform IP License | Media / Entertainment | 5.0 | 25.0 | 2024

20 | https://morningstar.com/stocks | E-commerce Platform Service License | Retail / E-commerce | 2.0 | 8.0 | 2024

21 | https://ipo.gov.uk/p-ipsum | Trademark Licensing (Apparel) | Apparel / Fashion | 6.0 | 15.0 | 2023

22 | https://uspto.gov/patents/search | Food & Beverage Brand License (US) | Food & Beverage | 5.0 | 12.0 | 2025

23 | https://marketwatch.com/tools/quotes | Biotech Licensing Deal (Experimental Drug) | Pharmaceuticals | 12.0 | 22.0 | 2024

24 | https://bloomberg.com/markets | Industrial Equipment Patent Transfer | Manufacturing | 3.5 | 15.0 | 2023

25 | https://morningstar.com/stocks | Telecom Equipment License Agreement | Telecommunications | 2.0 | 10.0 | 2025

26 | https://spglobal.com/en/research-insights | EV Battery Technology License | Automotive / Energy | 4.0 | 8.0 | 2024

27 | https://marketwatch.com/tools/quotes | Financial Analytics Software License | FinTech | 6.0 | 20.0 | 2023

28 | https://bloomberg.com/markets | CVD Semiconductor Manufacturing License | Industrial Manufacturing | 15.0 | 35.0 | 2025

29 | https://morningstar.com/stocks | Automotive Software Platform License | Automotive / Technology | 6.0 | 15.0 | 2024

30 | https://royaltyrange.com/ | Benchmark IP Licensing Study (Global) | Mixed Sectors | 8.0 | 20.0 | 2025

## Additional fields

## Dashboard widgets

- {"id": "1bdda717", "size": "small", "type": "metric", "title": "Average Arm's Length Profit Margin"}

- {"id": "e1d3b3a0", "size": "small", "type": "metric", "title": "Average Royalty Rate"}

- {"id": "fc61be9d", "size": "large", "type": "line", "title": "Profit Margin Trends Over Time"}

- {"id": "da44aedc", "size": "medium", "type": "bar", "title": "Top 10 Comparable Companies by Profit Margin"}

- {"id": "232d3ea7", "size": "medium", "type": "donut", "title": "Royalty Rate Distribution by Industry"}

- {"id": "0299a059", "size": "large", "type": "table", "title": "Detailed Intercompany Transaction Data"}

- {"id": "67b69b03", "size": "medium", "type": "horizontal_bar", "title": "Top 5 Royalty Rates by Country"}

- {"id": "5eb7b770", "size": "large", "type": "area", "title": "Cumulative Profit Margin Analysis"}

- {"id": "6877cddf", "size": "medium", "type": "insights", "title": "Key Observations on Profit Margins and Royalties"}

- {"id": "080eda15", "size": "large", "type": "line", "title": "Royalty Rate Trends Over Time"}

- {"id": "85bdf78c", "size": "medium", "type": "pie", "title": "Source Contribution to Data Pool"}

- {"id": "f9139f09", "size": "large", "type": "table", "title": "Recent Filings from SEC and IPO Registries"}

## Alerts

- {"id": "new_listing", "icon": "bi-plus-circle-fill", "item": "Royalty Rate for Tech Industry", "title": "New Royalty Rate Found", "source": "royaltyrange.com", "enabled": true, "send_to": "email", "severity": "success", "subtitle": "new data available from royaltyrange.com"}

- {"id": "price_change", "icon": "bi-tag-fill", "item": "Intercompany Transactions", "title": "Profit Margin Change Detected", "source": "sec.gov", "enabled": false, "send_to": "slack", "severity": "warning", "subtitle": "profit margin updated for 2025"}

- {"id": "new_listing", "icon": "bi-plus-circle-fill", "item": "SEC Filing", "title": "New Filing Available", "source": "edgar-online.com", "enabled": false, "send_to": "teams", "severity": "success", "subtitle": "recent filing added for Q4 2025"}

- {"id": "availability_change", "icon": "bi-exclamation-circle-fill", "item": "Royalty Data for 2026", "title": "Data Unavailable", "source": "ipo.gov.uk", "enabled": false, "send_to": "webhook", "severity": "danger", "subtitle": "data missing from global registry"}

- {"id": "coverage_gap", "icon": "bi-shield-fill", "item": "Industry Profit Margins", "title": "Coverage Gap Detected", "source": "spglobal.com", "enabled": false, "send_to": "email", "severity": "info", "subtitle": "missing data for healthcare sector"}

## Integrations

- api

- google-sheets

- salesforce

- email